Cipla Limited has informed the Exchange regarding Outcome of Board Meeting held on July 25, 2025.
CIPLA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cipla's Board, at its meeting on July 25, 2025, approved the grant of stock options and Employee Stock Appreciation Rights (ESARs) to employees. Under the ESOS 2013-A scheme, 5,264 stock options were granted at an exercise price of INR 2 per option, with a 2-year vesting period and 5-year exercise window post-vesting. Under the ESAR 2021 scheme, 18,178 ESARs were granted, also at an exercise price of INR 2 per share, with 3-year graded vesting and a 5-year exercise period. The disclosure has been made under SEBI's Listing Regulations and Share Based Employee Benefits Regulations. The exercise price of INR 2 is nominal compared to the current market price, making these grants valuable to employees.
This is a routine employee incentive grant and unlikely to materially affect share price. The total number of options/ESARs is small relative to Cipla's overall share base, so dilution impact is minimal. It signals the company's continued use of equity-based compensation to retain and motivate staff.